Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition - CNBC TV18
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Organigram has completed the acquisition of Sanity Group, a pharmacy business in Germany. Organigram acquisitions expand its healthcare M&A footprint by adding Sanity Group’s retail and distribution capabilities for medicinal products and pharmacy services. The Sanity Group acquisition strengthens Organigram’s strategic acquisition strategy in the German market, supporting broader access to pharmacy customers and supply channels. This add on acquisition is structured as an add on acquisition within healthcare M&A, with deal size undisclosed and status marked closed.
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Marksans Pharma→QliniQ
Jun 1, 2026
Frazier Healthcare Partners→Altruix
May 31, 2026
Signos
May 31, 2026
Sterling Bay→Pacific Center
May 29, 2026